BioNet-Asia’s DNA vaccine against COVID-19 raises hopes of Thai people

BioNet-Asia Company Limited has reported on the progress of its COVID-19 deoxyribonucleic acid (DNA) vaccine development and production, stating that it is now seeking FDA approval to conduct the first phase of human trials in October. Find out more from our special report.

Leave a Reply

Your email address will not be published. Required fields are marked *